New Delhi, February 24: Alembic Pharmaceuticals on Tuesday announced that it has received final approval from the US Food and Drug Administration to market its generic version of Efinaconazole Topical Solution 10 percent in the United States.The approval marks a significant regulatory...
alembic pharmaceuticals
anda
antifungal medication
bausch health americas, inc.
bse
efinaconazole topicalsolution
generic medication
jubliatopicalsolution
market size
onychomycosis
pharmaceutical industry
topicalsolution
trichophyton mentagrophytes
trichophyton rubrum
us food & drug administration
